Factors Associated With the Acceleration of Patient Enrollment in Clinical Studies: A Cross-Sectional Study
- PMID: 34776970
- PMCID: PMC8580154
- DOI: 10.3389/fphar.2021.753067
Factors Associated With the Acceleration of Patient Enrollment in Clinical Studies: A Cross-Sectional Study
Abstract
Under-recruitment in clinical trials is an issue worldwide. If the number of patients enrolled is lower than expected, based on the required sample size, then the reliability of the study results and their validation tend to be impaired. The current study therefore evaluated factors associated with accelerating patient enrollment using data from an ongoing multicenter prospective cohort study. The researchers encouraged research institutions to accelerate patient enrollment via e-mail, newsletters, telephone calls, and site visits. We analyzed the relationship between several potential factors associated with acceleration of patient enrollment including site visits and patient enrollment in a real clinical study. Data were collected from 106 research institutions that participated in a multicenter prospective cohort study. Results showed that the following parameters differed in terms of patient enrollment and non-enrollment: urban area (47.2 vs. 67.6%, p = 0.04), clinical research coordinator (CRC) participation in data input to electronic data capture (EDC) (41.7 vs. 11.8%, p < 0.01), and site visit (38.9 vs. 11.8%, p < 0.01). A multivariate analysis revealed that patient enrollment was significantly associated with urban area (odds ratio [OR] 0.33, 95% confidence interval [CI] 0.12-0.86, p = 0.02), CRC participation in data input to EDC (OR 5.02; 95% CI 1.49-16.8; p < 0.01), and site visit (OR 4.54, 95% CI 1.31-15.7, p = 0.01). In conclusion, site visits and CRC participation in data input to EDC had a significant effect on patient enrollment promotion. Moreover, hospitals in rural areas were more effective in promoting patient enrollment than those in urban areas.
Keywords: Japan; clinical research; clinical research coordinator; clinical research support; patient enrollment; site visit.
Copyright © 2021 Ueda, Nishizaki, Nojiri, Iwata, Miyauchi, Matsuyama, Sanada, Minamino and Daida.
Conflict of interest statement
RU, YN, SN, KM, TM and SS report no conflicts of interest. HI received research grants from Mitsubishi Tanabe Pharma Corp., Kowa Pharmaceuticals Co., Ltd., and Novo Nordisc and honoraria from Bayer Yakuhin, Ltd., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co. Ltd., MSD KK, Kowa Pharmaceuticals Co., Ltd., and Mitsubishi Tanabe Pharma Corp. KM received honoraria from Sanofi, Daiichi-Sankyo, Bayer Health Care, Bristol Myers Squibb, and MSD. HD received grants from Canon Medical Systems Corporation, Philips Japan, Ltd., Toho Holdings Co., Ltd., Asahi Kasei Corporation, and Inter Reha Co., Ltd.; scholarship grants from Nippon Boehringer Ingelheim Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., MSD K.K., Daiichi-Sankyo Company, Limited, Pfizer Co., Ltd., Mitsubishi Tanabe Pharma Corp., Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd., Shionogi and Co., Ltd., Actelion Pharmaceuticals Ltd., Actelion Ltd., Kowa Pharmaceutical Company Ltd., and Bayer Yakuhin, Ltd.; and lecture fees from Amgen Inc., Daiichi-Sankyo Company, Limited, Kowa Pharmaceutical Company Ltd., and MSD K.K.
Figures
Similar articles
-
Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.Clin Trials. 2012 Jun;9(3):358-66. doi: 10.1177/1740774512440760. Epub 2012 Mar 16. Clin Trials. 2012. PMID: 22426648
-
Examining palliative care program use and place of death in rural and urban contexts: a Canadian population-based study using linked data.Rural Remote Health. 2015 Apr-Jun;15(2):3134. Epub 2015 Jun 24. Rural Remote Health. 2015. PMID: 26103433
-
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).Circ Heart Fail. 2016 Sep;9(9):e002986. doi: 10.1161/CIRCHEARTFAILURE.116.002986. Circ Heart Fail. 2016. PMID: 27623769
-
Enrollment in clinical trials: institutional factors affecting enrollment in the cardiac arrhythmia suppression trial (CAST).Control Clin Trials. 1992 Dec;13(6):466-86. doi: 10.1016/0197-2456(92)90204-d. Control Clin Trials. 1992. PMID: 1334819 Clinical Trial.
-
Challenges of post-authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet.Pharmacoepidemiol Drug Saf. 2018 May;27(5):457-463. doi: 10.1002/pds.4331. Epub 2017 Oct 13. Pharmacoepidemiol Drug Saf. 2018. PMID: 29027301 Review.
Cited by
-
A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling.Br J Clin Pharmacol. 2022 Oct;88(10):4387-4402. doi: 10.1111/bcp.15372. Epub 2022 Jun 16. Br J Clin Pharmacol. 2022. PMID: 35484780 Free PMC article.
-
A cross-sectional survey on principal investigators' clinical research knowledge in Japan.Clin Transl Sci. 2023 Mar;16(3):459-466. doi: 10.1111/cts.13456. Epub 2022 Nov 22. Clin Transl Sci. 2023. PMID: 36382692 Free PMC article.
-
The status quo and influencing factors of clinical research nurses' participation in preoperative blood sampling in patients with pulmonary nodules.J Res Nurs. 2024 Aug;29(4-5):334-345. doi: 10.1177/17449871241246971. Epub 2024 Aug 12. J Res Nurs. 2024. PMID: 39291219 Free PMC article.
References
LinkOut - more resources
Full Text Sources